Items 61 to 70 of 215 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(S)-(−)-Pindolol | 26328-11-0 | sc-203688 sc-203688A | 10 mg 50 mg | $214.00 $882.00 | 1 | |
(S)-(-)-Pindolol is a unique serotonergic compound that exhibits a dual action on serotonin receptors, acting as both an antagonist and a partial agonist. Its stereochemistry allows for specific interactions with receptor binding sites, influencing receptor activity and downstream signaling. The compound's hydrophilic and lipophilic balance facilitates its penetration into various biological membranes, affecting its distribution and interaction with neurotransmitter systems. Its metabolic profile includes distinctive enzymatic pathways that contribute to its pharmacokinetic behavior. | ||||||
Zotepine | 26615-21-4 | sc-360895 sc-360895A | 10 mg 50 mg | $68.00 $256.00 | 3 | |
Zotepine is a distinctive serotonergic agent characterized by its complex binding affinity to serotonin receptors, particularly the 5-HT2 subtype. Its unique structural features enable selective interactions that modulate receptor conformation and signaling pathways. The compound's lipophilic nature enhances its ability to traverse cellular membranes, influencing its bioavailability and distribution. Additionally, Zotepine's metabolic pathways involve specific cytochrome P450 enzymes, impacting its overall kinetics and interactions within biological systems. | ||||||
Tianeptine sodium salt | 30123-17-2 | sc-204345 sc-204345A | 10 mg 50 mg | $125.00 $560.00 | 4 | |
Tianeptine sodium salt exhibits intriguing serotonergic properties through its selective modulation of serotonin reuptake mechanisms. Unlike traditional SSRIs, it enhances serotonin availability by promoting its uptake, leading to unique neurochemical dynamics. Its ionic nature facilitates solubility and interaction with biological membranes, while its distinct molecular structure allows for specific receptor binding, influencing downstream signaling cascades. This compound's kinetic profile is shaped by its interactions with various transporters and enzymes, contributing to its unique pharmacodynamics. | ||||||
Buspirone hydrochloride | 33386-08-2 | sc-202982 | 1 g | $92.00 | ||
Buspirone hydrochloride operates as a serotonergic agent by selectively engaging serotonin receptors, particularly the 5-HT1A subtype. Its unique binding affinity promotes a nuanced modulation of serotonergic signaling pathways, influencing neurotransmitter release and neuronal excitability. The compound's hydrophilic nature enhances its solubility in aqueous environments, facilitating effective interactions with cellular membranes. Additionally, its kinetic behavior is characterized by a rapid onset of action, driven by its specific receptor interactions and transport mechanisms. | ||||||
MDL-72222 | 40796-97-2 | sc-201132 | 50 mg | $185.00 | ||
MDL-72222 functions as a serotonergic compound by exhibiting a high affinity for various serotonin receptor subtypes, particularly 5-HT2. Its unique structural features allow for distinct conformational changes upon binding, which can alter downstream signaling cascades. The compound's lipophilic characteristics enhance its membrane permeability, promoting efficient cellular uptake. Furthermore, its interaction kinetics reveal a moderate dissociation rate, suggesting prolonged receptor engagement and sustained effects on serotonergic transmission. | ||||||
EMD 386088 hydrochloride | 54635-62-0 | sc-203575 sc-203575A | 10 mg 50 mg | $135.00 $440.00 | ||
EMD 386088 hydrochloride acts as a serotonergic agent by selectively modulating serotonin receptor activity, particularly influencing the 5-HT1A and 5-HT2A subtypes. Its unique molecular architecture facilitates specific hydrogen bonding and hydrophobic interactions, enhancing receptor affinity. The compound's dynamic binding profile indicates a slower association rate, which may lead to extended receptor occupancy. Additionally, its solubility properties contribute to effective distribution within biological systems, impacting serotonergic pathways. | ||||||
Fluvoxamine | 54739-18-3 | sc-207697 | 25 mg | $321.00 | 1 | |
Fluvoxamine functions as a serotonergic compound by engaging with serotonin receptors, notably the 5-HT2C subtype, through intricate molecular interactions. Its structural features promote specific electrostatic and van der Waals forces, enhancing binding efficiency. The compound exhibits a unique kinetic profile, characterized by a gradual dissociation rate, which may prolong its effects on receptor signaling. Furthermore, its lipophilicity aids in membrane permeability, influencing serotonergic transmission dynamics. | ||||||
Zimelidine dihydrochloride | 61129-30-4 | sc-203725 | 10 mg | $51.00 | ||
Zimelidine dihydrochloride acts as a serotonergic agent by selectively modulating serotonin reuptake mechanisms. Its unique structural conformation allows for specific interactions with serotonin transporters, facilitating enhanced neurotransmitter availability. The compound's distinct reaction kinetics reveal a rapid onset of action, while its hydrophilic nature influences solubility and distribution in biological systems. Additionally, Zimelidine's stereochemistry may contribute to its receptor affinity and selectivity. | ||||||
1-(1-Naphthyl)piperazine·HCl | 57536-86-4 | sc-201139 sc-201139A | 20 mg 100 mg | $53.00 $214.00 | ||
1-(1-Naphthyl)piperazine·HCl functions as a serotonergic compound through its ability to interact with serotonin receptors, influencing neurotransmission pathways. Its naphthyl moiety enhances π-π stacking interactions, promoting binding affinity. The compound exhibits unique kinetic properties, allowing for varied receptor activation profiles. Its solubility characteristics, influenced by the piperazine ring, facilitate effective distribution in diverse environments, impacting its overall bioavailability. | ||||||
WAY 629 hydrochloride | 57756-45-3 | sc-204393 sc-204393A | 10 mg 50 mg | $129.00 $548.00 | ||
WAY 629 hydrochloride acts as a serotonergic agent by selectively modulating serotonin receptor activity, particularly through its unique structural features. The compound's intricate molecular architecture allows for specific hydrogen bonding and hydrophobic interactions, enhancing receptor selectivity. Its dynamic conformational flexibility contributes to varied pharmacokinetic profiles, while its solubility in aqueous environments is influenced by the presence of the hydrochloride group, affecting its distribution and interaction with biological systems. | ||||||